Investing News

Danaher Buys Abcam for $5.7 Billion to Expand Its Product Offerings

Medical tool supplier Danaher moved to expand its product offerings by purchasing British biotech firm Abcam Plc for $5.7 billion, including debt.

Articles You May Like

What Is the Best $5 Stock to Buy in April? 3 Top Picks.
Medical AI Could Be Your Ticket to Riches: 3 Stocks to Buy
Compare the Best Mortgage Rates Today – April 25, 2024
3 Value Stocks to Buy at 52-Week Lows
Nvidia vs. Amazon Stock: Which One Scores Higher on These 3 Crucial Quality Metrics?